SE0004099D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- SE0004099D0 SE0004099D0 SE0004099A SE0004099A SE0004099D0 SE 0004099 D0 SE0004099 D0 SE 0004099D0 SE 0004099 A SE0004099 A SE 0004099A SE 0004099 A SE0004099 A SE 0004099A SE 0004099 D0 SE0004099 D0 SE 0004099D0
- Authority
- SE
- Sweden
- Prior art keywords
- novel compounds
- triazolo
- medicaments
- processes
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0004099A SE0004099D0 (sv) | 2000-11-09 | 2000-11-09 | Novel compounds |
| HK03108714.5A HK1056362B (en) | 2000-11-09 | 2001-11-07 | Triazolo[4,5-d]pyrimidine derivatives as anti-thrombotic agents |
| ES01983011T ES2274908T3 (es) | 2000-11-09 | 2001-11-07 | Derivados triazolo (4,5-d) pirimidinicos como agentes antitromboticos. |
| PCT/SE2001/002471 WO2002038570A1 (en) | 2000-11-09 | 2001-11-07 | Novel compounds |
| EP01983011A EP1335919B1 (en) | 2000-11-09 | 2001-11-07 | Triazolo[4,5-d]pyrimidine derivatives as anti-thrombotic agents |
| JP2002541102A JP4202752B2 (ja) | 2000-11-09 | 2001-11-07 | 新規化合物 |
| US10/415,248 US7034032B2 (en) | 2000-11-09 | 2001-11-07 | Cyclopentan-2-ol-1-yl-[1,2,3]triazolo[4,5-D]pyrimidine compounds |
| AU2002214467A AU2002214467A1 (en) | 2000-11-09 | 2001-11-07 | Novel compounds |
| AT01983011T ATE345343T1 (de) | 2000-11-09 | 2001-11-07 | Triazolo(4,5-d)pyrimidinderivate als antithrombotische verbindungen |
| DE60124581T DE60124581T2 (de) | 2000-11-09 | 2001-11-07 | Triazolo[4,5-d]pyrimidinderivate als antithrombotische verbindungen |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0004099A SE0004099D0 (sv) | 2000-11-09 | 2000-11-09 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE0004099D0 true SE0004099D0 (sv) | 2000-11-09 |
Family
ID=20281756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE0004099A SE0004099D0 (sv) | 2000-11-09 | 2000-11-09 | Novel compounds |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7034032B2 (sv) |
| EP (1) | EP1335919B1 (sv) |
| JP (1) | JP4202752B2 (sv) |
| AT (1) | ATE345343T1 (sv) |
| AU (1) | AU2002214467A1 (sv) |
| DE (1) | DE60124581T2 (sv) |
| ES (1) | ES2274908T3 (sv) |
| SE (1) | SE0004099D0 (sv) |
| WO (1) | WO2002038570A1 (sv) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0219746D0 (en) * | 2002-08-23 | 2002-10-02 | Inst Of Ex Botany Ascr | Azapurine derivatives |
| GB0512844D0 (en) * | 2005-06-23 | 2005-08-03 | Novartis Ag | Organic compounds |
| US7752475B2 (en) * | 2006-06-27 | 2010-07-06 | International Business Machines Corporation | Late data launch for a double data rate elastic interface |
| US7734944B2 (en) * | 2006-06-27 | 2010-06-08 | International Business Machines Corporation | Mechanism for windaging of a double rate driver |
| WO2008054795A2 (en) | 2006-10-31 | 2008-05-08 | Janssen Pharmaceutica, N.V. | Triazolopyrimidine derivatives as adp p2y12 receptor antagonists |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8826205D0 (en) * | 1988-11-09 | 1988-12-14 | Wellcome Found | Heterocyclic compounds |
| TW530058B (en) * | 1997-07-22 | 2003-05-01 | Astra Pharma Prod | Triazolo [4,5-d]pyrimidine compounos and their use and process for preparation |
-
2000
- 2000-11-09 SE SE0004099A patent/SE0004099D0/sv unknown
-
2001
- 2001-11-07 DE DE60124581T patent/DE60124581T2/de not_active Expired - Fee Related
- 2001-11-07 AT AT01983011T patent/ATE345343T1/de not_active IP Right Cessation
- 2001-11-07 WO PCT/SE2001/002471 patent/WO2002038570A1/en not_active Ceased
- 2001-11-07 ES ES01983011T patent/ES2274908T3/es not_active Expired - Lifetime
- 2001-11-07 AU AU2002214467A patent/AU2002214467A1/en not_active Abandoned
- 2001-11-07 EP EP01983011A patent/EP1335919B1/en not_active Expired - Lifetime
- 2001-11-07 US US10/415,248 patent/US7034032B2/en not_active Expired - Fee Related
- 2001-11-07 JP JP2002541102A patent/JP4202752B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ATE345343T1 (de) | 2006-12-15 |
| US7034032B2 (en) | 2006-04-25 |
| AU2002214467A1 (en) | 2002-05-21 |
| DE60124581T2 (de) | 2007-06-28 |
| JP4202752B2 (ja) | 2008-12-24 |
| JP2004513172A (ja) | 2004-04-30 |
| WO2002038570A1 (en) | 2002-05-16 |
| HK1056362A1 (en) | 2004-02-13 |
| ES2274908T3 (es) | 2007-06-01 |
| US20040023988A1 (en) | 2004-02-05 |
| EP1335919B1 (en) | 2006-11-15 |
| EP1335919A1 (en) | 2003-08-20 |
| DE60124581D1 (de) | 2006-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60204452D1 (de) | Pyrazolo[1,5]pyridinderivate | |
| IS6658A (is) | Ný efnasambönd | |
| WO2003095455A3 (en) | Substituted pyrazolopyrimidines | |
| TR200000197T2 (tr) | Yeni bileşimler | |
| ATE286500T1 (de) | 1,2,3,4-tetrahydroisochinolin-derivate | |
| GEP20084329B (en) | 5,7-diaminopyrazolo [4,3-d] pyrimidines useful in the treatment of hypertension | |
| TR200101567T2 (tr) | Yeni triazolo(4.5-D)pirimidin bileşimleri. | |
| MEP45308A (en) | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia | |
| PT1263724E (pt) | Novos compostos | |
| DE60212949D1 (de) | Antivirale pyrazolopyridin verbindungen | |
| SE0201544D0 (sv) | Novel compounds and thier use | |
| SE0302139D0 (sv) | Novel compounds | |
| EE200000048A (et) | Uudsed ühendid | |
| TR200002380T2 (tr) | Yeni triazolo (4,5-d) pirimidin bileşikleri | |
| SE0101038D0 (sv) | Novel compounds | |
| MY136297A (en) | Piperazine derivatives having sst1 antagonistic activity | |
| SE0303280D0 (sv) | Novel compounds | |
| PT1427417E (pt) | Derivados de 6, 7-di-hidroxitetra-hidroisoquinolina substituída em 3 para utilização como agentes antibacterianos | |
| SE9802574D0 (sv) | Novel compounds | |
| DE60201074D1 (en) | Pyrazolopyridinderivate | |
| SE0004099D0 (sv) | Novel compounds | |
| SE0302755D0 (sv) | Novel compounds | |
| SE9904128D0 (sv) | Novel compounds | |
| MXPA03010259A (es) | Nuevos derivados de 5-tio-ss-d-xilopiranosida, procedimiento de preparacion, composiciones farmaceuticas que los contienen y el uso terapeutico de los mismos. | |
| ATE272642T1 (de) | Thieno(2,3-d)pyrimidindione und ihre verwendung als pharmazeutische mittel |